Deoxyspergualin

CAS No. 98629-43-7

Deoxyspergualin( 15-deoxyspergualin | Spanidin | NSC 356894 | NKT-01 )

Catalog No. M16896 CAS No. 98629-43-7

Deoxyspergualin is a derivative of the antitumor antibiotic spergualin that binds specifically to Hsc70.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1593 Get Quote
50MG 3222 Get Quote
100MG 4410 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Deoxyspergualin
  • Note
    Research use only, not for human use.
  • Brief Description
    Deoxyspergualin is a derivative of the antitumor antibiotic spergualin that binds specifically to Hsc70.
  • Description
    Deoxyspergualin is a derivative of the antitumor antibiotic spergualin that binds specifically to Hsc70, also inhibits poly(rC) binding protein 2 (PCBP2).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    15-deoxyspergualin | Spanidin | NSC 356894 | NKT-01
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    HSP
  • Recptor
    HSP
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    98629-43-7
  • Formula Weight
    387.53
  • Molecular Formula
    C17H37N7O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(NC(O)C(NCCCCNCCCN)=O)CCCCCCNC(N)=N
  • Chemical Name
    7-[(Aminoiminomethyl)amino]-N-[2-[[4-[(3-aminopropyl)amino]butyl]amino]-1-hydroxy-2-oxoethyl]heptanamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Nadler SG, et al. Science. 1992 Oct 16;258(5081):484-6. 2. Panjwani N, et al. J Immunol. 1999 Aug 15;163(4):1936-42. 3. Murahashi M, et al. Biochem Biophys Res Commun. 2016 Aug 5;476(4):445-9.
molnova catalog
related products
  • PU-H71 HCl

    PU-H71 HCl (Zelavespib HCl) is a novel Hsp90 inhibitor, a novel purine-based analog, and a radiosensitizer that may be a promising agent for CIRT.

  • Pirenperone

    Pirenperone is a putative 5-HT2 receptor antagonist with the central antiserotonergic and antidopaminergic action.

  • AT13387

    AT13387 is a selective potent Hsp90 inhibitor with IC50 of 18 nM in A375 cells, displays a long duration of anti-tumor activity.